Emboline plots US-EU launch of embolic protection system following $20m fundraise

Emboline Secures Funding for Commercialization of Emboliner Embolic Protection System

March 13, 2026—Emboline, Inc., announced it has closed $20 million in growth capital that will support preparations for the commercial introduction of the company’s Emboliner embolic protection system while continuing development of additional technologies designed to reduce embolic risk during structural heart interventions. According to the company, the Emboliner device is designed to provide full cerebral and systemic embolic protection by ca…

Emboline secures funding to support launch of embolic protection system

Emboliner Emboline has closed US$20 Million in growth capital, supporting its efforts to advance new technology for reducing stroke and ischaemic damage during structural heart procedures. Emboline recently completed enrolment in the PROTECT H2H investigational device exemption (IDE) clinical trial, a prospective randomised study evaluating the Emboliner embolic protection system. The funding will support Emboline’s upcoming commercial launch ac…

Emboline plots US-EU launch of embolic protection system following $20m fundraise

Emboline expects that its technology designed to reduce stroke risk during structural heart procedures will launch in the US and Europe later this year.The post Emboline plots US-EU launch of embolic protection system following $20m fundraise appeared first on Medical Device Network.